| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Non-invasive prenatal cell-free fetal DNA testing for down syndrome and other chromosomal abnormalities
Authors:ID Strah, Darija (Author)
ID Ovniček, Petra (Author)
ID Bernik, Janez (Author)
Files:.pdf Zdravniski_vestnik_2015_Strah,_Ovnicek,_Bernik_Non-invasive_prenatal_cell-free_fetal_DNA_testing_for_down_syndrome_and_other_chromosomal.pdf (140,48 KB)
MD5: 9876E4A71CC22B857DA09782D5E060C9
 
URL http://vestnik.szd.si/index.php/ZdravVest/article/view/1390
 
Language:English
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Abstract:Background: Chorionic villus sampling and amniocentesis as definitive diagnostic procedures represent a gold standard for prenatal diagnosis of chromosomal abnormalities. The methods are invasive and lead to a miscarriage and fetal loss in approximately 0.5–1 %. Non-invasive prenatal DNA testing (NIPT) is based on the analysis of cell-free fetal DNA from maternal blood. It rep- resents a highly accurate screening test for detecting the most common fetal chromosomal abnormalities. In our study we present the results of NIPT testing in the Diagnostic Center Strah, Slovenia, over the last 3 years. Methods: In our study, 123 pregnant women from 11th to 18th week of pregnancy were included. All of them had First trimester assessment of risk for trisomy 21, done before NIPT testing. Results: 5 of total 6 high-risk NIPT cases (including 3 cases of Down syndrome and 2 cases of Klinefelter’s syndrome) were confirmed by fetal karyotyping. One case–Edwards syndrome was false positive. Patau syndrome, triple X syndrome or Turner syndrome were not observed in any of the cases. Furthermore, there were no false negative cases reported. In general, NIPT testing had 100 % sensitivity (95 % confidence interval: 46.29 %–100.00 %) and 98.95 % specificity (95 % confidence interval: 93.44 %–99.95 %). In determining Down syndrome alone, specificity (95 % confidence interval: 95.25 %- 100.00 %) and sensitivity (95 % confidence interval: 31.00 %–100.00 %) turned out to be 100 %. In 2015, the average turnaround time for analysis was 8.3 days from the day when the sample was taken. Repeated blood sampling was required in 2 cases (redraw rate = 1.6 %). Conclusions: Our results confirm that NIPT rep- resents a fast, safe and highly accurate advanced screening test for most common chromosomal abnormalities. In current clinical practice, NIPT would significantly decrease the number of unnecessary invasive procedures and the rate of fetal loss caused by invasive diagnostics.
Keywords:non-invasive prenatal DNA testing, chromosomal abnormalities, Down syndrome, pregnancy, fetal DNA
Publication status:Published
Publication version:Version of Record
Year of publishing:2015
Number of pages:str. 727-733
Numbering:Letn. 84, št. 11
PID:20.500.12556/DKUM-65616 New window
ISSN:1318-0347
UDC:618.29-07
ISSN on article:1318-0347
COBISS.SI-ID:284848896 New window
NUK URN:URN:SI:UM:DK:RBWM7F8X
Publication date in DKUM:10.05.2017
Views:1839
Downloads:437
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Zdravniški vestnik. glasilo Slovenskega zdravniškega društva
Publisher:Slovensko zdravniško društvo
ISSN:1318-0347
COBISS.SI-ID:32893696 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Licensing start date:10.05.2017

Secondary language

Language:Slovenian
Title:Neinvazivno predrojstveno testiranje prostih plodov DNA za downov sindrom in ostale kromosomske nepravilnosti
Abstract:Izhodišča: Amniocenteza in biopsija horionskih resic kot dokončni diagnostični metodi sta zlati standard predrojstvene diagnostike za ugotavljanje kromosomskih nepravilnosti ploda. Metodi sta invazivni in v približno 0,5–1 % povzročita prekinitev nosečnosti zaradi spontanega splava po posegu. Neinvazivno predrojstveno DNA testiranje (NIPT) temelji na analizi proste plodove DNA iz krvi nosečnice. Je visoko zanesljiv presejalni test za odkrivanje najpogostejših kromosomskih nepravilnosti ploda. V naši raziskavi predstavljamo rezultate testiranja NIPT v Diagnostičnem centru Strah v zadnjih 3 letih. Metode: V raziskavo je bilo vključenih 123 no- sečnic med 11. in 18. tednom nosečnosti. Vsaka nosečnica je opravila priporočeni ultrazvočni pregled zgodnje morfologije ploda z merjenjem nuhalne svetline. Določeno je bilo bodisi nizko bodisi visoko tveganje za kromosomske nepravilnosti. Rezultati: 5 od skupno 6 primerov, pri katerih je NIPT določil visoko tveganje (3 primeri Downovega sindroma in 2 primera Klinefelterjevega sindroma) je bilo potrjenih s kariotipizacijo. 1 primer – Edwardsov sindrom – je bil lažno pozitiven. Kromosomske nepravilnosti sindrom Patau, trojni X-sindrom ali Turnerjev sindrom niso bile zaznane pri nobeni nosečnici. O lažno negativnih primerih ni bilo poročano. Glede na podatke, pridobljene v raziskavi, je testiranje NIPT za vse omenjene kromosomske nepravilnosti pokazalo 100-odstotno občutljivost (95-odstotni interval zaupanja: 46,29 % – 100,00 %) in 98,95-odstotno specifičnost (95-odstotni interval zaupanja: 93,44 % – 99,95 %). Pri določanju le Downovega sindroma sta tako občutljivost (95 % interval zaupanja: 31,00 % – 100,00 %) kot specifičnost (95-odstotni interval zaupanja: 95,25 % – 100,00 %) enaki 100 %. V letu 2015 je bilo povprečno trajanje analize vzorca 8,3 dni od dneva odvzema krvi. V 2 primerih (1,6 %) je bil zaradi neuspešne analize potreben ponoven odvzem vzorca. Zaključki: Naši rezultati potrjujejo, da je NIPT hiter, varen in visoko zanesljiv napreden presejalni test za določanje najpogostejših kromosomskih nepravilnosti pri plodu. NIPT bi v do sedaj uveljavljeni klinični praksi lahko značilno znižal število nepotrebnih invazivnih preiskav in s tem tudi število spontanih splavov, ki jih invazivna diagnostika lahko povzroči.
Keywords:neinvazivno predrojstveno DNA testiranje, kromosomske nepravilnosti, Downov sindrom, nosečnost, fetalna DNA


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica